My full testimony before the U.S. Senate Committee on Health, Education, Labor and Pensions Video here thanks to Dr. Lucky Tran 👇

Honored and grateful to make the Web of Science #Clarivate list of highly cited researchers for 2024!!! Full list here: clarivate.com/highly-cited-r… #HighlyCited2024 Clarivate Clarivate for Academia & Government VA Research

1. What are the benefits and risks of GLP1? Our new study in @naturemedicine comprehensively maps all the benefits and risks of GLP-1 receptor agonists (GLP-1) (Ozempic, Wegovy, Mounjaro, Zepbound). By Yan Xie, Taeyoung Choi and me 🧵 nature.com/articles/s4159…

Excellent piece by Carolyn Barber, MD fortune.com/well/article/o…

Let me address this. We wrote the grant to do this project in 2018. It was funded in 2020. We deliberately delayed this to devote time and effort to addressing Covid and Long Covid. My team and I remain committed to working on LC, but we cannot default on our other commitments.

Great coverage by Jason Gale in Bloomberg Free link here: shorturl.at/4yos8

Our ACOS of the Research and Development department, Dr. Ziyad Al-Aly, has published a study in the Nature Medicine Journal yesterday! 'Mapping the effectiveness and risks of GLP-1 receptor agonists' Ziyad Al-Aly, MD Yan Xie VA Research VA STL Research nature.com/articles/s4159…

These important findings from this study have been covered all over the news. You can find the related articles below: Nature Medicine Journal: nature.com/articles/s4159… Bloomberg: bloomberg.com/.../addiction-…... Fortune: fortune.com/.../ozempic-gl… CNN: cnn.com/.../glp-1-medi…

Washington Post: washingtonpost.com/.../weight-los… Nature: nature.com/articles/s4159… BMJ: bmj.com/content/388/bm…